NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. , PRESENTING PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL ME
Published on 08/07/2025 at 18:04 | prnewswire.co.uk
en | boerse | 67978278 |
